Data from RITANZ shows IRD has accounted for 66% of all winding-up applications.
Shares up 16%, or 42c, to $2.91 in midday trading.
Your quick take on NBR's leading stories of the week.
The new funds will help the listed company in two major infrastructure projects and to return it to dividend payments next year.
Retirement village operator says its Australian expansion plans are on track
Sale process to start immediately.
Elsewhere, JP Morgan predicts the health of next year's oil market while OECD forecasts 2019.
The naturopathy company's trying to raise $2m.
AFT Pharmaceuticals reports reduced losses in latest results.
CRL took out New Zealand’s highest sustainability accolade last night.
